CN104878103B - Fam57b基因及其表达产物作为胆管癌诊治的靶标 - Google Patents
Fam57b基因及其表达产物作为胆管癌诊治的靶标 Download PDFInfo
- Publication number
- CN104878103B CN104878103B CN201510290995.4A CN201510290995A CN104878103B CN 104878103 B CN104878103 B CN 104878103B CN 201510290995 A CN201510290995 A CN 201510290995A CN 104878103 B CN104878103 B CN 104878103B
- Authority
- CN
- China
- Prior art keywords
- fam57b
- cholangiocarcinoma
- genes
- gene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
试剂 | 体积 |
正向引物 | 1μl |
反向引物 | 1μl |
SYBR Green聚合酶链式反应体系 | 12.5μl |
模板 | 2μl |
去离子水 | 补足25μl |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510290995.4A CN104878103B (zh) | 2015-06-01 | 2015-06-01 | Fam57b基因及其表达产物作为胆管癌诊治的靶标 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510290995.4A CN104878103B (zh) | 2015-06-01 | 2015-06-01 | Fam57b基因及其表达产物作为胆管癌诊治的靶标 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104878103A CN104878103A (zh) | 2015-09-02 |
CN104878103B true CN104878103B (zh) | 2018-08-24 |
Family
ID=53945776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510290995.4A Active CN104878103B (zh) | 2015-06-01 | 2015-06-01 | Fam57b基因及其表达产物作为胆管癌诊治的靶标 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104878103B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1177048C (zh) * | 2001-09-12 | 2004-11-24 | 上海新世界基因技术开发有限公司 | 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸 |
-
2015
- 2015-06-01 CN CN201510290995.4A patent/CN104878103B/zh active Active
Non-Patent Citations (3)
Title |
---|
Fam57b (Family with Sequence Similarity 57, Member B), a Novel Peroxisome Proliferator-activated Receptor γ Target Gene That Regulates Adipogenesis through Ceramide Synthesis;Yzumi Yamashita-Sugahara等;《THE JOURNAL OF BIOLOGICAL CHEMISTRY》;The American Society for Biochemistry and Molecular Biology, Inc.;20130215;第288卷(第7期);4522-4537 * |
人胆汁中潜在的胆管癌肿瘤标志物的筛选及相关蛋白的功能研究;沈健;《中国博士学位论文全文数据库 医药卫生科技辑》;20130115(第1期);E072-64 * |
基于RNA-seq技术的直肠癌肝转移预警基因的研究;林国生;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20150215(第2期);E072-508 * |
Also Published As
Publication number | Publication date |
---|---|
CN104878103A (zh) | 2015-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108949992B (zh) | 一种与食管鳞癌及其分级相关的生物标志物 | |
CN104962658B (zh) | Myoz1基因及其表达产物在帕金森病诊治中的应用 | |
CN109468382B (zh) | lncRNA在肺腺癌诊疗中的应用 | |
CN108531596A (zh) | 一种lncRNA作为生物标志物在胃癌诊治中的应用 | |
CN106967719B (zh) | 一种长链非编码rna作为前列腺癌分子标志物的应用 | |
CN106636443B (zh) | Dnah14基因在制备肿瘤诊治产品中的应用 | |
WO2020157070A1 (en) | Novel biomarkers and diagnostic profiles for prostate cancer | |
KR20110015013A (ko) | 결장직장암의 평가 방법 및 여기에 사용하기 위한 조성물 | |
CN107519193A (zh) | 食管鳞癌早期分子诊断标志物及其应用 | |
CN105886625B (zh) | Chka基因在制备食管癌诊治产品中的应用 | |
CA3067527A1 (en) | Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method | |
CN105385754B (zh) | 一种与胆管癌相关的分子标记物 | |
CN104878103B (zh) | Fam57b基因及其表达产物作为胆管癌诊治的靶标 | |
CN105385779B (zh) | 与直肠腺癌相关的基因标记物 | |
CN104894259A (zh) | Tex19基因在胆管癌诊断和治疗中的应用 | |
CN105838797B (zh) | 一种诊治食管癌的分子标志物 | |
CN112029864B (zh) | 一种乳腺癌miRNA检测试剂盒及其应用 | |
CN111534587B (zh) | 分子标志物5-tRF-His、乳腺癌检测试剂盒及其应用 | |
CN105755154A (zh) | 区分转移性与非转移性肺鳞癌的分子标志物 | |
CN105803068A (zh) | 一种诊治肺腺癌的分子标记物 | |
CN107184983B (zh) | 一种肺腺癌的诊治靶标 | |
CN104789689A (zh) | 作为肺腺癌诊治靶标的clec9a基因 | |
CN109371136A (zh) | 一种与肺腺癌相关的lncRNA及其应用 | |
EP2083087B1 (en) | Method for determining tongue cancer | |
CN105112554B (zh) | Clec1b基因在胆管癌诊断和治疗中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: FAM57B gene and expressed product thereof serving as target for diagnosis and treatment of bile duct cancer Effective date of registration: 20181225 Granted publication date: 20180824 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191206 Granted publication date: 20180824 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210401 Address after: 266000 room 2503, Qianshan building, D2, Qingdao International Innovation Park Phase II, No.1 Keyuan Weiyi Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Qingdao Yangshen biomedical Co.,Ltd. Address before: 100080 3103, fangting building, No.1 Shanyuan street, Haidian District, Beijing Patentee before: BEIJING MEDINTELL BIOMED INFORMATION TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |